APOLIPOPROTEIN B - ANVISA Registration 80464810613
Access comprehensive regulatory information for APOLIPOPROTEIN B in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810613 and manufactured by IMMUNDIAGNOSTIK AG. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80464810613
25351382947201814
09377976000152
Company Information
Dates and Status
Oct 29, 2018
VIGENTE
09/18/2025 19:00:01
APOLIPOPROTEÍNA B
Apo B Turbiquest
LABTEST DIAGNOSTICA S/A
10009010459
Aug 05, 2024
APOLIPOPROTEÍNA B
FAMÍLIA DE REAGENTE, CALIBRADOR E CONTROLES Optilite® Apolipoprotein B
THE BINDING SITE GROUP LTD
81357320130
Jun 26, 2023
APOLIPOPROTEÍNA B
Apolipoprotein B
THERMO FISHER SCIENTIFIC OY
80254180418
May 19, 2022
APOLIPOPROTEÍNA B
APOBT (Tina-quant Apolipoprotein B ver.2)
ROCHE DIAGNOSTICS GMBH
10287411405
Jul 22, 2019
APOLIPOPROTEÍNA B
Alinity c Apolipoprotein B Reagent Kit
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146502192
Mar 18, 2019

